Open Government Portal
About this information
Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.
The key things to remember about open data are:
- #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
- #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
- #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
Health Canada has adopted the International Conference on Harmonization (ICH) guideline Definitions for Genomic Biomarkers, Pharmacogenomics, Pharmacogenetics, Genomic Data and …
This Guidance document provides information on the interpretation and application of sections C.03.301 to C.03.320 of the Food and Drug …
Many drugs are being evaluated in Canada and around the world as potential treatments for COVID-19. Health Canada has authorized …
The Health and Biosciences Sector Regulatory Review Roadmap outlined a number of regulatory modernization commitments. These included plans to modernize …
Health Canada's Medical Devices Regulations regulate traditional devices effectively. New technologies, such as software as a medical device, need more …
Health Canada has a mandate to provide health information to Canadians so they can make informed decisions about their health. …
We're continuously looking ahead to understand the future drivers that will require us to adapt as a regulator. Our foresight …
Clinical trials are an important step in health product development. As products evolve, so do clinical trial types and designs. …
Scientific and technological advances are accelerating the pace of change in health care. This is leading to the development of …
The Canadian market now includes a much larger number of drugs that reflect a wider range of risks. Our drug …